Group 1 - Zhejiang Hengmei Health Technology Co., Ltd. (referred to as "Hengmei Health") has received the first round of inquiry from the Beijing Stock Exchange, focusing on business compliance, food safety risks, and other operational concerns [2] - The company plans to raise 501 million yuan through its IPO, which will be used for projects including the annual production of 5,780 tons of nutritional food and the establishment of a research and development center [4] - From 2022 to 2024, Hengmei Health's revenue increased from 587 million yuan to 1.072 billion yuan, while net profit rose from 40 million yuan to 103 million yuan, but the growth rates for both revenue and net profit are expected to decline significantly in 2024 [4] Group 2 - In the first quarter of 2025, Hengmei Health experienced a decline in performance, with revenue and net profit dropping by 10.14% and 23.12% year-on-year, respectively [4] - The company has faced management changes, with several executives resigning for personal reasons, raising concerns about the stability of its operations [5] - The Beijing Stock Exchange has requested Hengmei Health to analyze the impact of these management changes on its business operations and the potential risks associated with its market position and product offerings [5]
递表前创始股东、副总经理相继离职 衡美健康业绩下滑风险被问询
Xi Niu Cai Jing·2025-08-20 07:10